|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4866034A
(en)
|
1982-05-26 |
1989-09-12 |
Ribi Immunochem Research Inc. |
Refined detoxified endotoxin
|
|
US4987237A
(en)
|
1983-08-26 |
1991-01-22 |
Ribi Immunochem Research, Inc. |
Derivatives of monophosphoryl lipid A
|
|
US4877611A
(en)
|
1986-04-15 |
1989-10-31 |
Ribi Immunochem Research Inc. |
Vaccine containing tumor antigens and adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH0655749B2
(ja)
|
1989-09-20 |
1994-07-27 |
日本たばこ産業株式会社 |
リピッドａ単糖類縁体
|
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
US5593969A
(en)
|
1991-09-03 |
1997-01-14 |
Igen Incorporated |
Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
AU743114B2
(en)
|
1997-04-01 |
2002-01-17 |
Corixa Corporation |
Aqueous immunologic adjuvant compositions of monophosphoryl lipid A
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
US6500434B1
(en)
|
1998-04-23 |
2002-12-31 |
Medimmune, Inc. |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
ES2284287T3
(es)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
US6759241B1
(en)
|
1999-10-04 |
2004-07-06 |
University Of Maryland Biotechnology Institute |
Adjuvant comprising a lipopolysaccharide antagonist
|
|
WO2001078777A2
(en)
|
2000-04-13 |
2001-10-25 |
Mossman, Sally |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
AU2001271907A1
(en)
|
2000-07-07 |
2002-01-21 |
Medimmune, Inc. |
FimH adhesin proteins and methods of use
|
|
EP1313502A4
(en)
|
2000-08-18 |
2005-10-19 |
Medimmune Inc |
ADMINISTRATIVE PROCEDURE OF FIMH PROTEIN AS A VACCINE AGAINST HARNWAY INFECTIONS
|
|
WO2002102974A2
(en)
*
|
2000-12-08 |
2002-12-27 |
Medimmune, Inc. |
Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
CN101355928B
(zh)
|
2005-04-26 |
2013-05-22 |
卫材R&D管理株式会社 |
用于癌症免疫疗法的组合物和方法
|
|
ES2535084T3
(es)
|
2005-05-11 |
2015-05-05 |
Eth Zurich |
Proteínas N-glicosiladas recombinantes procedentes de células procariotas
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
ATE539079T1
(de)
|
2006-03-23 |
2012-01-15 |
Novartis Ag |
Imidazochinoxalinverbindungen als immunmodulatoren
|
|
CA2646891A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
|
SI2257307T1
(sl)
|
2008-02-20 |
2018-09-28 |
Glaxosmithkline Biologicals S.A. |
Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
PL2811981T3
(pl)
|
2012-02-07 |
2019-09-30 |
Infectious Disease Research Institute |
Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
|
|
CU24377B1
(es)
|
2013-05-18 |
2018-12-05 |
Aduro Biotech Inc |
Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
|
|
US9504743B2
(en)
|
2013-09-25 |
2016-11-29 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149522B2
(en)
*
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US20150086592A1
(en)
|
2013-09-25 |
2015-03-26 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9415101B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149521B2
(en)
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9415097B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
NZ723328A
(en)
|
2014-02-24 |
2018-01-26 |
Glycovaxyn Ag |
Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture
|
|
US10722580B2
(en)
*
|
2015-05-13 |
2020-07-28 |
University Of Washington |
Compositions and methods for treatment and prevention of uropathogenic E. coli infection
|
|
CN107847580B
(zh)
|
2015-07-07 |
2022-08-12 |
扬森疫苗与预防公司 |
针对rsv的疫苗
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
TW201946650A
(zh)
|
2018-03-12 |
2019-12-16 |
美商詹森藥物公司 |
針對腹內感染之疫苗
|
|
WO2021123360A1
(en)
|
2019-12-20 |
2021-06-24 |
Vib Vzw |
Nanobody exchange chromatography
|
|
MY209568A
(en)
|
2020-01-16 |
2025-07-22 |
Janssen Pharmaceuticals Inc |
Fimh mutant, compositions therewith and use thereof
|
|
CN116888140A
(zh)
|
2021-01-12 |
2023-10-13 |
杨森制药公司 |
FimH突变体、其组合物及其用途
|